IPG Photonics (IPGP) Expected to Post Quarterly Earnings on Tuesday

IPG Photonics (NASDAQ:IPGP) is expected to announce its Q2 2026 results before the market opens on Tuesday, August 4th. Analysts expect IPG Photonics to post earnings of $0.3655 per share and revenue of $279.9750 million for the quarter. IPG Photonics has set its Q2 2026 guidance at 0.250-0.550 EPS. Parties are encouraged to explore the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Tuesday, August 4, 2026 at 10:00 AM ET.

IPG Photonics (NASDAQ:IPGP) last announced its earnings results on Tuesday, May 5th. The semiconductor company reported $0.29 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.03). IPG Photonics had a return on equity of 2.84% and a net margin of 2.78%.The company had revenue of $265.50 million for the quarter, compared to the consensus estimate of $256.99 million. During the same period in the previous year, the firm posted $0.09 EPS. The business’s quarterly revenue was up 16.5% on a year-over-year basis. On average, analysts expect IPG Photonics to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

IPG Photonics Stock Performance

Shares of IPGP opened at $85.06 on Friday. The firm has a market cap of $3.61 billion, a P/E ratio of 123.28, a price-to-earnings-growth ratio of 2.47 and a beta of 0.94. IPG Photonics has a 52 week low of $71.35 and a 52 week high of $155.82. The firm’s 50-day simple moving average is $107.39 and its 200 day simple moving average is $111.26.

Insiders Place Their Bets

In other IPG Photonics news, Director Tang Agnes sold 1,511 shares of the business’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $117.85, for a total value of $178,071.35. Following the completion of the sale, the director owned 9,588 shares of the company’s stock, valued at $1,129,945.80. The trade was a 13.61% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Valentin Gapontsev Trust I sold 56,316 shares of the stock in a transaction that occurred on Tuesday, July 21st. The stock was sold at an average price of $102.31, for a total transaction of $5,761,689.96. Following the transaction, the insider owned 6,670,283 shares in the company, valued at approximately $682,436,653.73. The trade was a 0.84% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 136,716 shares of company stock worth $14,277,206. 37.50% of the stock is currently owned by insiders.

Hedge Funds Weigh In On IPG Photonics

A number of hedge funds have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of IPG Photonics by 20.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 39,024 shares of the semiconductor company’s stock valued at $2,541,000 after acquiring an additional 6,741 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of IPG Photonics by 0.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 87,469 shares of the semiconductor company’s stock worth $5,523,000 after purchasing an additional 744 shares during the period. Jane Street Group LLC raised its stake in IPG Photonics by 79.4% in the first quarter. Jane Street Group LLC now owns 122,105 shares of the semiconductor company’s stock valued at $7,710,000 after purchasing an additional 54,026 shares in the last quarter. Prudential Financial Inc. acquired a new position in IPG Photonics in the second quarter valued at about $205,000. Finally, Invesco Ltd. lifted its position in IPG Photonics by 0.3% during the second quarter. Invesco Ltd. now owns 105,525 shares of the semiconductor company’s stock worth $7,244,000 after purchasing an additional 272 shares during the period. Institutional investors own 93.79% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on IPGP. Zacks Research cut IPG Photonics from a “strong-buy” rating to a “hold” rating in a report on Monday, May 4th. Wall Street Zen lowered IPG Photonics from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Needham & Company LLC lifted their price target on IPG Photonics from $110.00 to $120.00 and gave the stock a “buy” rating in a report on Friday, July 17th. Weiss Ratings restated a “sell (d+)” rating on shares of IPG Photonics in a research note on Wednesday, June 24th. Finally, Citigroup upped their price objective on IPG Photonics from $105.00 to $150.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Six research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, IPG Photonics presently has a consensus rating of “Moderate Buy” and a consensus target price of $137.17.

IPG Photonics Company Profile

IPG Photonics Corporation is a global leader in the design and manufacture of high-performance fiber lasers and amplifiers used in industrial, medical, scientific, and telecommunications applications. The company’s core products include ytterbium and erbium fiber lasers, diode lasers, and fiber amplifiers that deliver high power and efficiency for precision cutting, welding, marking, and engraving. IPG’s systems are engineered to optimize process speed, reliability, and energy consumption, making them a preferred choice for advanced manufacturing environments.

In addition to stand-alone laser sources, IPG offers turnkey laser systems and integrated solutions tailored to sectors such as automotive, electronics, aerospace, additive manufacturing, and life sciences.